271 related articles for article (PubMed ID: 30915709)
1. Systematic computational identification of promiscuity cliff pathways formed by inhibitors of the human kinome.
Miljković F; Vogt M; Bajorath J
J Comput Aided Mol Des; 2019 Jun; 33(6):559-572. PubMed ID: 30915709
[TBL] [Abstract][Full Text] [Related]
2. Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.
Miljković F; Bajorath J
J Comput Aided Mol Des; 2020 Jan; 34(1):1-10. PubMed ID: 31792884
[TBL] [Abstract][Full Text] [Related]
3. Exploring structure-promiscuity relationships using dual-site promiscuity cliffs and corresponding single-site analogs.
Hu H; Bajorath J
Bioorg Med Chem; 2020 Jan; 28(1):115238. PubMed ID: 31818631
[TBL] [Abstract][Full Text] [Related]
4. Data structures for compound promiscuity analysis: promiscuity cliffs, pathways and promiscuity hubs formed by inhibitors of the human kinome.
Miljković F; Bajorath J
Future Sci OA; 2019 Jul; 5(7):FSO404. PubMed ID: 31428450
[TBL] [Abstract][Full Text] [Related]
5. Systematic assessment of structure-promiscuity relationships between different types of kinase inhibitors.
Hu H; Bajorath J
Bioorg Med Chem; 2021 Jul; 41():116226. PubMed ID: 34082305
[TBL] [Abstract][Full Text] [Related]
6. Mapping Biological Activities to Different Types of Molecular Scaffolds: Exemplary Application to Protein Kinase Inhibitors.
Dimova D; Bajorath J
Methods Mol Biol; 2018; 1825():327-337. PubMed ID: 30334211
[TBL] [Abstract][Full Text] [Related]
7. Activity profile relationships between structurally similar promiscuous compounds.
Hu Y; Bajorath J
Eur J Med Chem; 2013 Nov; 69():393-8. PubMed ID: 24077530
[TBL] [Abstract][Full Text] [Related]
8. Rationalizing Promiscuity Cliffs.
Dimova D; Bajorath J
ChemMedChem; 2018 Mar; 13(6):490-494. PubMed ID: 29024534
[TBL] [Abstract][Full Text] [Related]
9. Promiscuity analysis of a kinase panel screen with designated p38 alpha inhibitors.
González-Medina M; Miljković F; Haase GS; Drueckes P; Trappe J; Laufer S; Bajorath J
Eur J Med Chem; 2020 Feb; 187():112004. PubMed ID: 31881458
[TBL] [Abstract][Full Text] [Related]
10. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Promiscuity Cliffs Using Machine Learning.
Blaschke T; Feldmann C; Bajorath J
Mol Inform; 2021 Jan; 40(1):e2000196. PubMed ID: 32881355
[TBL] [Abstract][Full Text] [Related]
12. Mapping of inhibitors and activity data to the human kinome and exploring promiscuity from a ligand and target perspective.
Hu Y; Kunimoto R; Bajorath J
Chem Biol Drug Des; 2017 Jun; 89(6):834-845. PubMed ID: 27933727
[TBL] [Abstract][Full Text] [Related]
13. Analyzing Promiscuity at the Level of Active Compounds and Targets.
Bajorath J
Mol Inform; 2016 Dec; 35(11-12):583-587. PubMed ID: 27870240
[TBL] [Abstract][Full Text] [Related]
14. Systematic assessment of coordinated activity cliffs formed by kinase inhibitors and detailed characterization of activity cliff clusters and associated SAR information.
Dimova D; Stumpfe D; Bajorath J
Eur J Med Chem; 2015 Jan; 90():414-27. PubMed ID: 25461890
[TBL] [Abstract][Full Text] [Related]
15. Identifying representative kinases for inhibitor evaluation via systematic analysis of compound-based target relationships.
Laufkötter O; Laufer S; Bajorath J
Eur J Med Chem; 2020 Oct; 204():112641. PubMed ID: 32745818
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Data-Driven Assessment of Non-Kinase Targets of Inhibitors of the Human Kinome.
Mobasher M; Vogt M; Xerxa E; Bajorath J
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540679
[TBL] [Abstract][Full Text] [Related]
17. Deep Learning Enhancing Kinome-Wide Polypharmacology Profiling: Model Construction and Experiment Validation.
Li X; Li Z; Wu X; Xiong Z; Yang T; Fu Z; Liu X; Tan X; Zhong F; Wan X; Wang D; Ding X; Yang R; Hou H; Li C; Liu H; Chen K; Jiang H; Zheng M
J Med Chem; 2020 Aug; 63(16):8723-8737. PubMed ID: 31364850
[TBL] [Abstract][Full Text] [Related]
18. Method for the evaluation of structure-activity relationship information associated with coordinated activity cliffs.
Dimova D; Stumpfe D; Bajorath J
J Med Chem; 2014 Aug; 57(15):6553-63. PubMed ID: 25014781
[TBL] [Abstract][Full Text] [Related]
19. Matched molecular pair analysis of small molecule microarray data identifies promiscuity cliffs and reveals molecular origins of extreme compound promiscuity.
Dimova D; Hu Y; Bajorath J
J Med Chem; 2012 Nov; 55(22):10220-8. PubMed ID: 23050678
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel inhibitors of tropomyosin-related kinase A through the structure-based virtual screening with homology-modeled protein structure.
Park H; Chi O; Kim J; Hong S
J Chem Inf Model; 2011 Nov; 51(11):2986-93. PubMed ID: 22017333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
